These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 31366886)

  • 21. Suppression of autophagy in osteocytes does not modify the adverse effects of glucocorticoids on cortical bone.
    Piemontese M; Onal M; Xiong J; Wang Y; Almeida M; Thostenson JD; Weinstein RS; Manolagas SC; O'Brien CA
    Bone; 2015 Jun; 75():18-26. PubMed ID: 25700544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Communication between ephrinB2 and EphB4 within the osteoblast lineage.
    Martin TJ; Allan EH; Ho PW; Gooi JH; Quinn JM; Gillespie MT; Krasnoperov V; Sims NA
    Adv Exp Med Biol; 2010; 658():51-60. PubMed ID: 19950015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low concentrations of TNF-α promote osteogenic differentiation via activation of the ephrinB2-EphB4 signalling pathway.
    Wang L; Zhang J; Wang C; Qi Y; Du M; Liu W; Yang C; Yang P
    Cell Prolif; 2017 Feb; 50(1):. PubMed ID: 27726217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Author Correction: Increased autophagy in EphrinB2-deficient osteocytes is associated with elevated secondary mineralization and brittle bone.
    Vrahnas C; Blank M; Dite TA; Tatarczuch L; Ansari N; Crimeen-Irwin B; Nguyen H; Forwood MR; Hu Y; Ikegame M; Bambery KR; Petibois C; Mackie EJ; Tobin MJ; Smyth GK; Oakhill JS; Martin TJ; Sims NA
    Nat Commun; 2019 Nov; 10(1):5073. PubMed ID: 31685818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteocyte- and late osteoblast-derived NOTUM reduces cortical bone mass in mice.
    Nilsson KH; Henning P; El Shahawy M; Wu J; Koskela A; Tuukkanen J; Perret C; Lerner UH; Ohlsson C; Movérare-Skrtic S
    Am J Physiol Endocrinol Metab; 2021 May; 320(5):E967-E975. PubMed ID: 33749332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bradykinin receptors and EphB2/EphrinB2 pathway in response to high glucose-induced osteoblast dysfunction and hyperglycemia-induced bone deterioration in mice.
    Wu M; Ai W; Chen L; Zhao S; Liu E
    Int J Mol Med; 2016 Mar; 37(3):565-74. PubMed ID: 26782642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part I of IV parts: mechanisms of calcium transfer between blood and bone and their cellular basis: morphological and kinetic approaches to bone turnover.
    Parfitt AM
    Metabolism; 1976 Jul; 25(7):809-44. PubMed ID: 781470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Constitutive protein kinase A activity in osteocytes and late osteoblasts produces an anabolic effect on bone.
    Kao RS; Abbott MJ; Louie A; O'Carroll D; Lu W; Nissenson R
    Bone; 2013 Aug; 55(2):277-87. PubMed ID: 23583750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pigment epithelium derived factor suppresses expression of Sost/Sclerostin by osteocytes: implication for its role in bone matrix mineralization.
    Li F; Song N; Tombran-Tink J; Niyibizi C
    J Cell Physiol; 2015 Jun; 230(6):1243-9. PubMed ID: 25363869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted Disruption of NF1 in Osteocytes Increases FGF23 and Osteoid With Osteomalacia-like Bone Phenotype.
    Kamiya N; Yamaguchi R; Aruwajoye O; Kim AJ; Kuroyanagi G; Phipps M; Adapala NS; Feng JQ; Kim HK
    J Bone Miner Res; 2017 Aug; 32(8):1716-1726. PubMed ID: 28425622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammatory macrophages interrupt osteocyte maturation and mineralization via regulating the Notch signaling pathway.
    Wang S; Xiao L; Prasadam I; Crawford R; Zhou Y; Xiao Y
    Mol Med; 2022 Sep; 28(1):102. PubMed ID: 36058911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 3D Interrelationship between Osteocyte Network and Forming Mineral during Human Bone Remodeling.
    Ayoubi M; van Tol AF; Weinkamer R; Roschger P; Brugger PC; Berzlanovich A; Bertinetti L; Roschger A; Fratzl P
    Adv Healthc Mater; 2021 Jun; 10(12):e2100113. PubMed ID: 33963821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin D regulates osteocyte survival and perilacunar remodeling in human and murine bone.
    Rolvien T; Krause M; Jeschke A; Yorgan T; Püschel K; Schinke T; Busse B; Demay MB; Amling M
    Bone; 2017 Oct; 103():78-87. PubMed ID: 28666969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autocrine and Paracrine Regulation of the Murine Skeleton by Osteocyte-Derived Parathyroid Hormone-Related Protein.
    Ansari N; Ho PW; Crimeen-Irwin B; Poulton IJ; Brunt AR; Forwood MR; Divieti Pajevic P; Gooi JH; Martin TJ; Sims NA
    J Bone Miner Res; 2018 Jan; 33(1):137-153. PubMed ID: 28914969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autophagy in osteoblasts is involved in mineralization and bone homeostasis.
    Nollet M; Santucci-Darmanin S; Breuil V; Al-Sahlanee R; Cros C; Topi M; Momier D; Samson M; Pagnotta S; Cailleteau L; Battaglia S; Farlay D; Dacquin R; Barois N; Jurdic P; Boivin G; Heymann D; Lafont F; Lu SS; Dempster DW; Carle GF; Pierrefite-Carle V
    Autophagy; 2014; 10(11):1965-77. PubMed ID: 25484092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation.
    Poole KE; van Bezooijen RL; Loveridge N; Hamersma H; Papapoulos SE; Löwik CW; Reeve J
    FASEB J; 2005 Nov; 19(13):1842-4. PubMed ID: 16123173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of autophagy in osteocytes mimics skeletal aging.
    Onal M; Piemontese M; Xiong J; Wang Y; Han L; Ye S; Komatsu M; Selig M; Weinstein RS; Zhao H; Jilka RL; Almeida M; Manolagas SC; O'Brien CA
    J Biol Chem; 2013 Jun; 288(24):17432-40. PubMed ID: 23645674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear alpha NAC influences bone matrix mineralization and osteoblast maturation in vivo.
    Meury T; Akhouayri O; Jafarov T; Mandic V; St-Arnaud R
    Mol Cell Biol; 2010 Jan; 30(1):43-53. PubMed ID: 19884350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted disruption of BMP signaling through type IA receptor (BMPR1A) in osteocyte suppresses SOST and RANKL, leading to dramatic increase in bone mass, bone mineral density and mechanical strength.
    Kamiya N; Shuxian L; Yamaguchi R; Phipps M; Aruwajoye O; Adapala NS; Yuan H; Kim HK; Feng JQ
    Bone; 2016 Oct; 91():53-63. PubMed ID: 27402532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteocytes control myeloid cell proliferation and differentiation through Gsα-dependent and -independent mechanisms.
    Azab E; Chandler KB; Uda Y; Sun N; Hussein A; Shuwaikan R; Lu V; Costello CE; McComb ME; Divieti Pajevic P
    FASEB J; 2020 Aug; 34(8):10191-10211. PubMed ID: 32557809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.